Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
2018-12-06 $0.0300 $0.0700 $0.0280 $0.0400 242 643
2018-12-04 $0.0300 $0.0400 $0.0300 $0.0360 36 068
2018-12-03 $0.0300 $0.0425 $0.0300 $0.0300 53 622
2018-11-30 $0.0350 $0.0400 $0.0303 $0.0350 62 373
2018-11-29 $0.0350 $0.0490 $0.0350 $0.0350 76 024
2018-11-28 $0.0425 $0.0500 $0.0300 $0.0440 93 712
2018-11-27 $0.0360 $0.0500 $0.0360 $0.0420 98 745
2018-11-26 $0.0547 $0.0565 $0.0500 $0.0520 113 106
2018-11-23 $0.0520 $0.0560 $0.0520 $0.0560 5 948
2018-11-21 $0.0600 $0.0690 $0.0520 $0.0656 248 290
2018-11-20 $0.0620 $0.0650 $0.0600 $0.0600 15 994
2018-11-19 $0.0610 $0.0750 $0.0600 $0.0600 11 676
2018-11-16 $0.0750 $0.0750 $0.0600 $0.0610 9 561
2018-11-15 $0.0650 $0.0700 $0.0600 $0.0700 22 553
2018-11-14 $0.0700 $0.0750 $0.0650 $0.0650 50 038
2018-11-13 $0.0660 $0.0680 $0.0660 $0.0680 4 149
2018-11-12 $0.0750 $0.0750 $0.0680 $0.0680 15 169
2018-11-09 $0.0684 $0.0743 $0.0680 $0.0680 32 936
2018-11-08 $0.0700 $0.0750 $0.0700 $0.0750 56 774
2018-11-07 $0.0714 $0.0743 $0.0678 $0.0714 38 770
2018-11-06 $0.0705 $0.0746 $0.0661 $0.0678 18 307
2018-11-05 $0.0750 $0.0750 $0.0640 $0.0706 14 607
2018-11-02 $0.0400 $0.0750 $0.0400 $0.0695 145 264
2018-11-01 $0.0601 $0.0800 $0.0600 $0.0710 86 419
2018-10-31 $0.0070 $0.0712 $0.0070 $0.0710 19 259
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT